This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ropella, K. M. Articles by Swiryn, S. Search for Related Content PubMed PubMed Citation Articles by Ropella, K. M. Articles by Swiryn, S.

Circulation, Vol 77, 1047-1054, Copyright © 1988 by American Heart Association

ARTICLES

Effects of procainamide on intra-atrial [corrected] electrograms during atrial fibrillation: implications [corrected] for detection algorithms [published erratum appears in Circulation 1988 Jun;77(6):1344]

KM Ropella, AV Sahakian, JM Baerman and S Swiryn
Department of Biomedical, Engineering, Northwestern University, Chicago, IL.

The effects of antiarrhythmic drugs on electrograms have implications for arrhythmia-detection algorithms in implantable antitachycardia devices. Filtered and unfiltered intra-atrial electrograms were analyzed in eight patients who received procainamide (50 mg/min iv, up to 1000 mg) during 11 episodes of atrial fibrillation. Continuous recordings were made before, during, and after the infusion. The recordings were digitized, divided into 4.27 sec segments, and analyzed for atrial rate, median frequency and amplitude probability density function. Significant differences were noted before and after infusion of procainamide for atrial rate (498 +/- 97 vs 356 +/- 146 beats/min; p less than .005), median frequency (5.50 +/- 1.22 vs 4.24 +/- 0.99 Hz; p less than .0005), and density (58.3 +/- 13.9% vs 69.1 +/- 15.0%; p less than .005). Pre- and postprocainamide values were compared with published criteria for detection of atrial fibrillation. Before procainamide, only 2.3%, 5.7%, and 3.4% of the data segments failed to meet criteria for atrial fibrillation by rate, frequency content, and density, respectively. In contrast, after procainamide, 50%, 36.4%, and 28.4% of the data segments failed to meet these same criteria, despite electrograms still meeting morphologic criteria for atrial fibrillation. Thus procainamide resulted in changes sufficient to cause failure of published criteria for detection of atrial fibrillation. These findings have broad implications for the function of antitachycardia devices in patients receiving antiarrhythmic drug therapy.

This article has been cited by other articles:

				S. Petrutiu, A. V. Sahakian, and S. Swiryn Abrupt changes in fibrillatory wave characteristics at the termination of paroxysmal atrial fibrillation in humans Europace, July 1, 2007; 9(7): 466 - 470. [Abstract] [Full Text] [PDF]

				A. Bollmann, K. Sonne, H.-D. Esperer, I. Toepffer, J. J Langberg, and H. U Klein Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG Cardiovasc Res, October 1, 1999; 44(1): 60 - 66. [Abstract] [Full Text] [PDF]